Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D J Horsfall

Showing results (51-60 of 52) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 52 results.
Cancer Research|May 27, 1999
Elevated levels of peritumoral chondroitin sulfate are predictive of poor prognosis in patients treated by radical prostatectomy for early-stage prostate cancerC Ricciardelli, D I Quinn, W A Raymond, et al.
Molecular Endocrinology (Baltimore, Md.)|January 6, 2001
Mutations at the boundary of the hinge and ligand binding domain of the androgen receptor confer increased transactivation functionG Buchanan, M Yang, J M Harris, et al.
Pageof 6

Showing results (51-60 of 52) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 52 results.
Cancer Research|May 27, 1999
Elevated levels of peritumoral chondroitin sulfate are predictive of poor prognosis in patients treated by radical prostatectomy for early-stage prostate cancerC Ricciardelli, D I Quinn, W A Raymond, et al.
Molecular Endocrinology (Baltimore, Md.)|January 6, 2001
Mutations at the boundary of the hinge and ligand binding domain of the androgen receptor confer increased transactivation functionG Buchanan, M Yang, J M Harris, et al.
Pageof 6